Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B, Sengupta J N
Department of Pediatrics, Division of Pediatric Gastroenterology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Neuroscience. 2007 Sep 21;148(4):1021-32. doi: 10.1016/j.neuroscience.2007.05.034. Epub 2007 Aug 23.
The transient receptor potential vanilloid 1 receptor (TRPV1) is an important nociceptor involved in neurogenic inflammation. We aimed to examine the role of TRPV1 in experimental colitis and in the development of visceral hypersensitivity to mechanical and chemical stimulation. Male Sprague-Dawley rats received a single dose of trinitrobenzenesulfonic acid (TNBS) in the distal colon. In the preemptive group, rats received the TRPV1 receptor antagonist JYL1421 (10 mumol/kg, i.v.) or vehicle 15 min prior to TNBS followed by daily doses for 7 days. In the post-inflammation group, rats received JYL1421 daily for 7 days starting on day 7 following TNBS. The visceromotor response (VMR) to colorectal distension (CRD), intraluminal capsaicin, capsaicin vehicle (pH 6.7) or acidic saline (pH 5.0) was assessed in all groups and compared with controls and naïve rats. Colon inflammation was evaluated with H&E staining and myeloperoxidase (MPO) activity. TRPV1 immunoreactivity was assessed in the thoraco-lumbar (TL) and lumbo-sacral (LS) dorsal root ganglia (DRG) neurons. In the preemptive vehicle group, TNBS resulted in a significant increase in the VMR to CRD, intraluminal capsaicin and acidic saline compared the JYL1421-treated group (P<0.05). Absence of microscopic colitis and significantly reduced MPO activity was also evident compared with vehicle-treated rats (P<0.05). TRPV1 immunoreactivity in the TL (69.1+/-4.6%) and LS (66.4+/-4.2%) DRG in vehicle-treated rats was increased following TNBS but significantly lower in the preemptive JYL1421-treated group (28.6+/-3.9 and 32.3+/-2.3 respectively, P<0.05). JYL1421 in the post-inflammation group improved microscopic colitis and significantly decreased the VMR to CRD compared with vehicle (P<0.05, >/=30 mm Hg) but had no effect on the VMR to chemical stimulation. TRPV1 immunoreactivity in the TL and LS DRG was no different from vehicle or naïve controls. These results suggest an important role for TRPV1 channel in the development of inflammation and subsequent mechanical and chemical visceral hyperalgesia.
瞬时受体电位香草酸受体1(TRPV1)是参与神经源性炎症的重要伤害感受器。我们旨在研究TRPV1在实验性结肠炎以及内脏对机械和化学刺激的超敏反应发展中的作用。雄性Sprague-Dawley大鼠在结肠远端接受单剂量的三硝基苯磺酸(TNBS)。在预处理组中,大鼠在TNBS给药前15分钟静脉注射TRPV1受体拮抗剂JYL1421(10 μmol/kg)或溶剂,随后连续7天每日给药。在炎症后组中,大鼠在TNBS给药后第7天开始连续7天每日接受JYL1421治疗。评估所有组对结肠扩张(CRD)、腔内辣椒素、辣椒素溶剂(pH 6.7)或酸性盐水(pH 5.0)的内脏运动反应(VMR),并与对照组和未处理的大鼠进行比较。用苏木精-伊红(H&E)染色和髓过氧化物酶(MPO)活性评估结肠炎症。评估胸腰段(TL)和腰骶段(LS)背根神经节(DRG)神经元中的TRPV1免疫反应性。在预处理溶剂组中,与JYL1421治疗组相比,TNBS导致对CRD、腔内辣椒素和酸性盐水的VMR显著增加(P<0.05)。与溶剂处理的大鼠相比,显微镜下结肠炎的缺失和MPO活性的显著降低也很明显(P<0.05)。溶剂处理的大鼠中,TNBS后TL(69.1±4.6%)和LS(66.4±4.2%)DRG中的TRPV1免疫反应性增加,但在预处理JYL1421治疗组中显著降低(分别为28.6±3.9和32.3±2.3,P<0.05)。与溶剂相比,炎症后组中的JYL1421改善了显微镜下结肠炎,并显著降低了对CRD的VMR(P<0.05,≥30 mmHg),但对化学刺激的VMR没有影响。TL和LS DRG中的TRPV1免疫反应性与溶剂组或未处理的对照组没有差异。这些结果表明TRPV1通道在炎症发展以及随后的机械性和化学性内脏痛觉过敏中起重要作用。